Advertising in dermatology journals: Journals' and journal editors' policies, practices, and attitudes

Journal of the American Academy of Dermatology

Volumn 55, Issue 1, 2006, Pages 116-122

  Bartus, Cynthia L ^b   Katz, Kenneth A ^a,b  

^a Department of Dermatology ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADVERTIZING; ARTICLE; ATTITUDE; CLINICAL PRACTICE; DERMATOLOGY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; INFORMATION RETRIEVAL; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL STAFF; PEER REVIEW; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION;

ADVERTISING; ATTITUDE; DERMATOLOGY; EDITORIAL POLICIES; PERIODICALS; PROFESSIONAL PRACTICE;

EID: 33744975519     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.01.046     Document Type: Article

References (52)

1. US General Accounting Office. Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations. Washington, DC; US General Accounting Office: 2002 Oct. Report No.: GAO-03-177. Available at: http://www.gao.gov/new.items/d03177.pdf. Accessed April 17, 2006.
2. Liebman M. Listen up, publishers say-journal advertising sells!. Med Marketing Media 35 (2000) 89-94
3. Avorn J., Chen M., and Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 73 (1982) 4-8
4. Spiller L.D., and Wymer Jr. W.W. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians. Health Mark Q 19 (2001) 91-106
5. Bhattacharyya T., Tornetta III P., Healy W.L., and Einhorn T.A. The validity of claims made in orthopedic print advertisements. J Bone Joint Surg Am 85A (2003) 1224-1228
6. Blondeel L. Evidence based advertising? Advertisement for nifedipine does not mention admitted shortcomings of study. BMJ 315 (1997) 1621-1622
7. Cooper R.J., Schriger D.L., Wallace R.C., Mikulich V.J., and Wilkes M.S. The quantity and quality of scientific graphs in pharmaceutical advertisements. J Gen Intern Med 18 (2003) 294-297
8. Fletcher R.H. Adverts in medical journals: caveat lector. Lancet 361 (2003) 10-11
9. Gitanjali B., Shashindran C.H., Tripathi K.D., and Sethuraman K.R. Are drug advertisements in Indian edition of BMJ unethical?. BMJ 315 (1997) 459
10. Gutknecht D.R. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract 14 (2001) 197-200
11. Herxheimer A., Lundborg C.S., and Westerholm B. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards. Int J Health Serv 23 (1993) 161-172
12. Hogan D.J., Sarel D., Canas A., Bellman B., Eaglstein W., Hogan L.A., et al. An analysis of advertisements in the Journal of the American Academy of Dermatology, 1980 and 1990. J Am Acad Dermatol 28 (1993) 993-997
13. Hopcroft D. References in medical advertising-too often a blend of fact and fiction?. N Z Med J 115 (2002) 294-295
14. Lankinen K.S., Levola T., Marttinen K., Puumalainen I., and Helin-Salmivaara A. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. Pharmacoepidemiol Drug Saf 13 (2004) 789-795
15. Loke T.W., Koh F.C., and Ward J.E. Pharmaceutical advertisement claims in Australian medical publications. Med J Aust 177 (2002) 291-293
16. Mindell J., and Kemp T. Evidence based advertising? Only two fifths of advertisements cited published, peer reviewed references. BMJ 315 (1997) 1622
17. Oliver J.J., and Maxwell S.R. Journals should select drug advertisements more carefully. BMJ 326 (2003) 1211
18. Smart S., and Williams C. Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence. BMJ 315 (1997) 1622-1623
19. Villanueva P., Peiro S., Librero J., and Pereiro I. Accuracy of pharmaceutical advertisements in medical journals. Lancet 361 (2003) 27-32
20. Vitry A., and Mansfield P. Drug advertisements in medical journals. Lancet 350 (1997) 1477-1478
21. Vlassov V., Mansfield P., Lexchin J., and Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing?. West J Med 174 (2001) 391-394
22. Wilkes M.S., Doblin B.H., and Shapiro M.F. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med 116 (1992) 912-919
23. Angel J.F. Pharmaceutical ads in journals. Ann Intern Med 117 (1992) 616-619
24. Beary III J.F. Pharmaceutical ads in journals. Ann Intern Med 117 (1992) 616
25. Liebman M. Pharmaceutical ads in journals. Ann Intern Med 117 (1992) 617
26. Cowden AL, Katz KA. FDA surveillance of dermatology-related prescription-medicine advertising in the USA, 2000-2003. Br J Dermatol doi: 10.1111/j.1365-2133.2006.07168.x.
27. Katz K.A. Amevive's advertisements: problematic?. Arch Dermatol 141 (2005) 1603-1604
28. Portman R.M. Statement on advertising in the Journal. J Am Acad Dermatol 52 (2005) 32A
29. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Updated October 2004. Philadelphia. Available from: URL:http://www.icmje.org/index.html#about. Accessed August 23, 2005.
30. Giles J. Journals lack explicit policies for separating eds from ads. Nature 434 (2005) 549
31. Glass A.R. Pharmaceutical advertising in the Journal. N Engl J Med 327 (1992) 1688-1689
32. Goldstein J.H. Of mugs and marketing. JAMA 265 (1991) 2391-2392
33. Orentlicher D., and Hehir M.K. Advertising policies of medical journals: conflicts of interest for journal editors and professional societies. J Law Med Ethics 27 (1999) 113-121
34. Pierach C.A. Pharmaceutical advertising in the journal. N Engl J Med 327 (1992) 1688-1689
35. American Medical Association. Principles governing advertising in publications of the American Medical Association. September 2002. Chicago. Available from: URL:http://pubs.ama-assn.org/misc/advertise.dtl#principles. Accessed September 6, 2005.
36. Wilkes M.S., and Kravitz R.L. Policies, practices, and attitudes of North American medical journal editors. J Gen Intern Med 10 (1995) 443-450
37. Pitkin R.M. Ethical and quasi-ethical issues in medical editing and publishing. Croat Med J 39 (1998) 95-101
38. Gartner L.M. The "fourth part" of Pediatrics: 50 years of display advertising. Pediatrics 102 (1998) 177-185
39. Rennie D. Editors and advertisements. What responsibility do editors have for the advertisements in their journals?. JAMA 265 (1991) 2394-2396
40. Smith R. Medical journals and pharmaceutical companies: uneasy bedfellows. BMJ 326 (2003) 1202-1205
41. Kassirer J.P. Pharmaceutical advertising in the journal: editor's reply. N Engl J Med 327 (1992) 1689
42. Carrasquillo O., and Goodman R.L. Pharma's bad karma: resistance is not futile. J Gen Intern Med 18 (2003) 315-316
43. Tsai A.C. Conflicts between commercial and scientific interests in pharmaceutical advertising for medical journals. Int J Health Serv 33 (2003) 751-768
44. Landefeld C.S., Chren M.M., Quinn L.M., and Siddique R.M. A 4-year study of the volume of drug advertisements in leading medical journals. [abstract]. J Gen Intern Med 10 Suppl (1995) 111
45. Vedantam S. Business, science clash at medical journal. Washington Post. February 7, 2004;sect A:2.
46. Archives of Dermatology. Advertising principles. Arch Dermatol 141 (2005) 926
47. Dermatologic Surgery. Display advertising. Dermatol Surg 31 (2005) page following page 891
48. Journal of Drugs in Dermatology. Advertising. J Drugs Dermatol 4 (2004) page following page 262
49. Archives of Dermatological Research Copyright. Arch Dermatol Res 151 (2004) A2
50. Australasian Journal of Dermatology. Disclaimer. Australas J Dermatol 44 (2003) inside front cover
51. British Journal of Dermatology. Disclaimer. Br J Dermatol 151 (2004) first page
52. Journal of Cutaneous Medicine and Surgery. Copyright. J Cutan Med Surg 8 (2004) a2